Charles E. Binkley, MD, Michael S. Politz, MA, and Brian P. Green, PhD
If the safe-and-effective standard for judging devices’ potential as therapy or enhancement is inadequate, one might wonder whether BCI regulation should be overseen by the FDA.
AMA J Ethics. 2021;23(9):E745-749. doi:
10.1001/amajethics.2021.745.
Dr Charles Binkley joins Ethics Talk to discuss his article, coauthored with Michael Politz and Dr Brian Green: "Who, If Not the FDA, Should Regulate Implantable Brain-Computer Interface Devices?"
Matthew William McCarthy, MD and Joseph J. Fins, MD
Hospital medicine must expand its mission to include the teaching of medical ethics, professionalism, and communication to trainees during clinical rounds.
AMA J Ethics. 2017;19(6):528-532. doi:
10.1001/journalofethics.2017.19.6.peer2-1706.